Rimonabant-Induced Persistent Vomiting

Samir Kumar Praharaj, Sujit Sarkhel

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Rimonabant is a selective cannabinoid-1 receptor blocker, which may reduce body weight and improve cardiometabolic risk factors in patients who are overweight or obese. Rimonabant is generally well tolerated but the most common drugrelated adverse event reported in trials is nausea. We report a case of persistent vomiting associated with rimonabant therapy for reduction of body weight gain in a patient with paranoid schizophrenia, which resolved following discontinuation of medication and symptomatic treatment.

Original languageEnglish
Pages (from-to)49-50
Number of pages2
JournalGerman Journal of Psychiatry
Volume16
Issue number1
Publication statusPublished - 24-07-2013

Fingerprint

rimonabant
Vomiting
Body Weight
Cannabinoid Receptor Antagonists
Paranoid Schizophrenia
Nausea
Weight Gain
Therapeutics

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health

Cite this

Praharaj, Samir Kumar ; Sarkhel, Sujit. / Rimonabant-Induced Persistent Vomiting. In: German Journal of Psychiatry. 2013 ; Vol. 16, No. 1. pp. 49-50.
@article{35df95868e374ef696dd2a8740dc214c,
title = "Rimonabant-Induced Persistent Vomiting",
abstract = "Rimonabant is a selective cannabinoid-1 receptor blocker, which may reduce body weight and improve cardiometabolic risk factors in patients who are overweight or obese. Rimonabant is generally well tolerated but the most common drugrelated adverse event reported in trials is nausea. We report a case of persistent vomiting associated with rimonabant therapy for reduction of body weight gain in a patient with paranoid schizophrenia, which resolved following discontinuation of medication and symptomatic treatment.",
author = "Praharaj, {Samir Kumar} and Sujit Sarkhel",
year = "2013",
month = "7",
day = "24",
language = "English",
volume = "16",
pages = "49--50",
journal = "German Journal of Psychiatry",
issn = "1433-1055",
publisher = "University of Goettingen",
number = "1",

}

Praharaj, SK & Sarkhel, S 2013, 'Rimonabant-Induced Persistent Vomiting', German Journal of Psychiatry, vol. 16, no. 1, pp. 49-50.

Rimonabant-Induced Persistent Vomiting. / Praharaj, Samir Kumar; Sarkhel, Sujit.

In: German Journal of Psychiatry, Vol. 16, No. 1, 24.07.2013, p. 49-50.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Rimonabant-Induced Persistent Vomiting

AU - Praharaj, Samir Kumar

AU - Sarkhel, Sujit

PY - 2013/7/24

Y1 - 2013/7/24

N2 - Rimonabant is a selective cannabinoid-1 receptor blocker, which may reduce body weight and improve cardiometabolic risk factors in patients who are overweight or obese. Rimonabant is generally well tolerated but the most common drugrelated adverse event reported in trials is nausea. We report a case of persistent vomiting associated with rimonabant therapy for reduction of body weight gain in a patient with paranoid schizophrenia, which resolved following discontinuation of medication and symptomatic treatment.

AB - Rimonabant is a selective cannabinoid-1 receptor blocker, which may reduce body weight and improve cardiometabolic risk factors in patients who are overweight or obese. Rimonabant is generally well tolerated but the most common drugrelated adverse event reported in trials is nausea. We report a case of persistent vomiting associated with rimonabant therapy for reduction of body weight gain in a patient with paranoid schizophrenia, which resolved following discontinuation of medication and symptomatic treatment.

UR - http://www.scopus.com/inward/record.url?scp=84880814317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880814317&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84880814317

VL - 16

SP - 49

EP - 50

JO - German Journal of Psychiatry

JF - German Journal of Psychiatry

SN - 1433-1055

IS - 1

ER -